Profile
Graham Parry worked as Biology Director at Attenuon, LLC and as Principal at Motility, Inc. He also worked as Vice President-Technical Operations at True North Therapeutics, Inc. from 2014 to 2017.
Parry received his undergraduate degree from Brunel University and his doctorate degree from the University of London.
Former positions of Graham Parry
| Companies | Position | End |
|---|---|---|
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Chief Tech/Sci/R&D Officer | 2016-12-31 |
Motility, Inc. | Corporate Officer/Principal | - |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Training of Graham Parry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Brunel University
Brunel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Motility, Inc. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
- Stock Market
- Insiders
- Graham Parry
















